FundedNext Stretches Its Loss Buffer to 12% on a New Labs Account and Puts the Daily Cap Back In
FundedNext has pushed out the second account in its Labs program, and the number everyone will notice is the maximum loss limit: 12% on a $25,000 two-step challenge. That is two percentage points more room than the 10% ceiling the firm applies to its standard Stellar 2-Step model, and it arrives while almost every serious prop firm is arguing over the same question. How much rope should a trader get before the account is gone?
The account, labelled FNL:002, went live on Tuesday at $149.99 with an 85% profit share and a static drawdown. Traders can hold up to five of them. And unlike the first Labs release, this one puts the daily loss limit firmly back in place.
What FundedNext Actually Put on the Table
The spec sheet rewards a close read rather than a skim of the marketing line. On a $25,000 account, the 12% maximum loss limit works out to $3,000 of total downside, against $2,500 under a conventional 10% rule. Alongside it sits a 4% daily loss limit, or $1,000.
- Account size: $25,000, priced at $149.99
- Maximum loss limit: 12% static, equal to $3,000
- Daily loss limit: 4%, equal to $1,000
- Profit targets: 8% in Phase 1, 6% in Phase 2
- Minimum activity: two profitable days per phase, each requiring at least 1% ($250) in closed profit
- Profit share: 85%, applied from the first funded payout
- Risk cap: 3% on any single position
- Leverage: 1:100 on forex, 1:25 on metals, energies and indices
The static structure matters as much as the headline percentage. A trailing drawdown tightens as equity climbs, which quietly punishes traders who give back part of an open profit. A fixed $3,000 floor stays where it is for the whole evaluation, so position sizing can be planned across sessions instead of recalculated after every winning trade. Anyone who has studied why so few traders make it through an evaluation will recognise how often the exit comes from drawdown mechanics rather than from a genuinely bad idea.
News trading is prohibited. Positions can be carried overnight and over weekends. There is no strike system and no separate margin rule, which leaves the daily and maximum loss limits as the only meaningful account-level controls. The model runs on MetaTrader 5 outside the United States and on Match-Trader for US clients.
The “3-Day Payout” Label Is Not About Calendar Days
FundedNext is marketing FNL:002 with a “3-Day Payout” badge, and this is the part traders should read twice. The condition is not three days on a calendar. It is three qualifying days, each of which needs at least 1% ($250) in closed profit.
In practice that sets a cumulative floor of $750 in realised profit before a payout request can even be made. Profit is credited to the day a position closes rather than the day it opens, so a trade held across a session boundary counts once, on exit. Hit the three qualifying days and the withdrawal request opens up immediately, with no weekly or monthly window to wait for.
It is a fair structure, and arguably a more honest one than a fixed calendar cycle, because it ties access to profit rather than to the passage of time. But the label does the firm more favours than it does the trader, and a slow fortnight makes “3-Day Payout” a considerably longer wait than it sounds.
Labs Test Two Reverses Parts of Labs Test One
The most interesting thing about FNL:002 is what it changes relative to FNL:001, launched when Labs opened in July.
FNL:001 was a $99.99 one-step account on $50,000 with no daily loss limit at all, offset by a $2,000 end-of-day trailing maximum loss and a 40% consistency rule. It allowed news trading, asked for a 6% target, paid 80%, and closed the account after five payouts.
FNL:002 goes the other way on nearly every axis: two phases instead of one, a daily cap restored, static drawdown instead of trailing, no consistency rule, news trading banned, and a higher 85% split. FundedNext has not said whether this account also retires after a set number of withdrawals, nor how many seats exist or how long it stays open.
Read together, the two releases look less like a product line and more like a controlled experiment. Labs is a limited-seat track precisely so the firm can watch how traders behave under opposing rule sets before committing anything to the main lineup. Removing the daily cap and then restoring it inside four weeks is the behaviour of a firm collecting data, not a firm that has made up its mind. Traders comparing this against the established programs can see how the economics differ in our breakdown of FTMO, FundedNext and The5%ers on fees, rules and payouts.
Where It Sits Against the Rest of the Market
FNL:002 is not the first account to stretch past a 10% loss limit. Pipcy applied a 12% absolute maximum to its Classic Challenge back in May, paired with no daily drawdown, payouts inside 48 hours and a profit share reaching 95%. E8 Markets went in the opposite direction with E8 Zero in July, using a very tight 3% static loss limit, scrapping the consistency rule and permitting daily payout requests, but deactivating the account after five withdrawals.
What separates FNL:002 is that it keeps a daily cap while widening the overall one. That combination targets a specific failure pattern: the trader who survives any single session comfortably but gets ground down across a volatile week. Whether that pattern is common enough to justify the design is exactly what Labs exists to find out.
What This Means for the Broader Prop Industry
Two things stand out, and neither is really about FundedNext.
The first is that the competitive battleground has moved. For most of the last two years, firms fought on price and on discount codes. FNL:002 costs $149.99 for $25,000 in buying power, which is not cheap by 2026 standards. The pitch is not the price, it is the rule set. When a firm is willing to charge more and compete on how survivable the evaluation feels, that is a sign the market has matured past pure price-cutting and is starting to compete on product quality. That is healthier for traders, even when individual accounts cost more.
The second is the emergence of public experimentation as a strategy. Prop firms have always tweaked rules, but usually quietly and usually after the fact. Running a named, limited-seat lab where two consecutive releases contradict each other is a different posture. It is transparent in a way the industry has rarely been, and it also transfers some of the testing cost onto paying traders, which is a trade-off worth naming plainly. Expect competitors to copy the format, because it generates both data and marketing at the same time.
The caution for traders is unchanged. A wider loss buffer does not make an 8% and 6% two-phase target easier to reach, and it does not change the fact that most accounts are lost to the psychology of trading under evaluation pressure rather than to arithmetic. Two extra percentage points buy time. They do not buy an edge.
